Bluejay Diagnostics (BJDX) Change in Inventory (2020 - 2022)

Bluejay Diagnostics (BJDX) posted Change in Inventory of -$221924.0 for Q2 2022, down 124.85% sequentially from $893174.0 in Q1 2022.

Bluejay Diagnostics (BJDX) Change in Inventory (2020 - 2022) Analysis & Trends

Bluejay Diagnostics has reported Change in Inventory for 2 years, with the latest figure at -$221924.0 in Q2 2022.

Quarterly Change in Inventory changed N/A year-over-year to -$221924.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $671250.0 (changed N/A YoY) and the FY2021 annual result came in at -$84762.0, down 118.76% from the prior year.
Change in Inventory retreated to -$221924.0 in Q2 2022 per BJDX's latest filing, from $893174.0 in the prior quarter.
Over five years, Change in Inventory peaked at $893174.0 in Q1 2022 and troughed at -$221924.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	301.00 Mn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	113.00 Mn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	-399.00 Mn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	133.00 Mn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	23.50 Mn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	36.40 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	139.00 Mn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	-131.35 Mn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	73.30 Mn
10	Bluejay Diagnostics	1.89 Mn	1.89 Mn	-	-

Download Data